Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & State Efforts
Doctors urge access to psychedelic therapies in New Mexico
Physicians and researchers are urging New Mexico legislators to allow the use of psychedelic mushrooms in mental health therapy aimed at overcoming depression, anxiety, psychological trauma and alcoholism.
United States
House Will Vote on These Marijuana and Psychedelic Measures As Part of Defense Bill This Week
A key congressional committee met on Tuesday to consider more than 1,200 amendments to a large-scale defense bill, including about a dozen measure related to marijuana and psychedelics. Several of those major proposed drug policy reforms have now been cleared for votes on the House floor this week.…
Oregon Psilocybin Services Act
Psilocybin a Main Topic of Deschutes County Public Hearing Wednesday
BUSINESS INSIDER
Lawmakers, regulators, advocates, and executives are going to have a huge hand in shaping the future of Oregon’s psilocybin industry.
Lawmakers, regulators, advocates, and executives are going to have a huge hand in shaping the future of Oregon’s psilocybin industry.
Oregon Health Authority taking public comment on psilocybin
State health officials will take public comment on the rulemaking process for psilocybin.
Rural Oregon counties are lining up against psilocybin launch
Umatilla County one of the latest counties to put a psilocybin service center ban on the November ballot.
Right to Try
DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients
The Drug Enforcement Administration (DEA) may soon find itself in federal court again over its refusal to grant a doctor access to psilocybin to treat his terminally ill patients under “Right-to-Try” (RTT) laws. It’s been more than a year since Washington State physician Sunil Aggarwal of the Advanc…
Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care
Their efforts could benefit countless others in need of an end-of-life measure
Right To Try Laws: Psilocybin For End-Of-Life Care Poses Ongoing Battle With The DEA - Benzinga
A group of terminally ill patients seeking psilocybin therapy will likely take the Drug Enforcement Administration (DEA) to federal court once again over the agency’s denial to grant access to the treatment under Right To Try (RTT) laws, The Microdose
Research, Science & Therapy
Study Determines Psychedelic Mushroom Microdoses Can Improve Mood and Mental Health - Neuroscience News
Study reveals those who microdosed psilocybin for 30 days showed greater improvements in mood, mental health, and psychomotor abilities than those who did not microdose. The findings have positive implications for the use of psychedelics to help treat mental health disorders.
Mycelium Matters: How Mushrooms Can Address Climate Change
The climate crisis demands innovative solutions. The Climate Academy is bringing those solutions to the world. Paid and Presented by Grounded.
Culture
Ann Shulgin, pioneer of psychedelics in therapy, dies at 91
SAN FRANCISCO (AP) — Ann Shulgin, who together with her late husband Alexander Shulgin pioneered the use of psychedelic drugs in psychotherapy and co-wrote two seminal books on the subject, has died at the age of 91.
Michael Pollan on the Psychedelic Renaissance and Netflix’s New ‘How to Change Your Mind’ Documentary
A Q&A with TIME
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
